{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:58:26Z","timestamp":1790413106309,"version":"4.1.0"},"reference-count":30,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Swedish Association of the Pharmaceutical Industry"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2736997","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:08:05Z","timestamp":1790410085000},"page":"2406-2422","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the consistency of overall survival extrapolations in Swedish health technology assessment reports of oncology treatments using extended follow-up data"],"prefix":"10.1080","volume":"29","author":[{"given":"M\u00e1t\u00e9","family":"Szilcz","sequence":"first","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Viti Science AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Mogard","sequence":"additional","affiliation":[{"name":"Parexel International","place":["Z\u00fcrich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Ekman","sequence":"additional","affiliation":[{"name":"AstraZeneca AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Lindgren","sequence":"additional","affiliation":[{"name":"Takeda Pharma AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Pfizer AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Johannesen","sequence":"additional","affiliation":[{"name":"AstraZeneca AB","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Medin","sequence":"additional","affiliation":[{"name":"Department of Learning, Informatics, Management and Ethics, Karolinska Institutet","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12472398"},{"key":"e_1_3_6_3_1","unstructured":"TLV. Tandv\u00e5rds- och l\u00e4kemedelsf\u00f6rm\u00e5nsverkets allm\u00e4nna r\u00e5d. 2017. TLVAR 2017:1. January 26 [cited 2026 Jun 15]. Available from: https:\/\/www.tlv.se\/download\/18.467926b615d084471ac3230c\/1510316374332\/TLVAR_2017_1.pdf."},{"key":"e_1_3_6_4_1","unstructured":"Latimer N. NICE DSU Technical Support Document 14: survival Analysis for Economic Evaluations alongside Clinical Trials - Extrapolation with Patient-Level Data. 2011. [cited 2026 Jun 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK395885\/pdf\/Bookshelf_NBK395885.pdf."},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2021-000094"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00853-x"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-019-00806-4"},{"key":"e_1_3_6_8_1","unstructured":"NICE. NICE health technology evaluations: the manual; 2023."},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.07.009"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X16639900"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-024-01423-6"},{"key":"e_1_3_6_12_1","unstructured":"TLV. Underlag f\u00f6r beslut i landstingen: keytruda (pembrolizumab). 2015. [cited 2026 Jun 15]. Available from: https:\/\/www.tlv.se\/download\/18.467926b615d084471ac33ac6\/1510316360861\/Kunskapsunderlag_keytruda.pdf."},{"key":"e_1_3_6_13_1","unstructured":"TLV. Underlag f\u00f6r beslut i landstingen: kyprolis (karfilzomib). 2016. [cited 2026 Jun 15]. Available from: https:\/\/www.tlv.se\/download\/18.467926b615d084471ac33b0c\/1510316358781\/Kunskapsunderlag_kyprolis.pdf."},{"key":"e_1_3_6_14_1","unstructured":"TLV. Underlag f\u00f6r beslut i landstingen: perjeta (pertuzumab). 2018. [cited 2026 Jun 15]. Available from: https:\/\/www.tlv.se\/download\/18.7a6e902e1663e6b655894e93\/1538982747864\/bes_underlag180924_perjeta.pdf."},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1547303"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.09.553"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462322000125"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2304459"},{"key":"e_1_3_6_19_1","unstructured":"TLV. Beslut - H\u00e4r hittar du de beslut TLV fattar om subvention av l\u00e4kemedel och f\u00f6rbrukningsartiklar samt tillsynsbeslut. TLV. September 16 2022; [cited 2026 Jun 17]. Available from: https:\/\/www.tlv.se\/lakemedelsforetag\/beslut.html?start=20260101-00000000-AM&end=20261231-235959999-PM"},{"key":"e_1_3_6_20_1","unstructured":"WebPlotDigitizer. Extract data from charts. 2024. [cited 2026 Jun 15]. Available from: https:\/\/automeris.io\/."},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v070.i08"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1362"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263661"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-1694-0_15"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-021-00263-w"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-152"},{"key":"e_1_3_6_28_1","unstructured":"Rutherford MJ Lambert PC Sweeting MJ et al. NICE DSU Technical Support Document 21: flexible Methods for Survival Analysis. 2020. [cited 2026 Jun 18]. Available from: https:\/\/sheffield.ac.uk\/sites\/default\/files\/2022-02\/TSD21-Flex-Surv-TSD-21_Final_alt_text.pdf."},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12454579"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.04.011"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2020.02.002"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2736997","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13696998.2026.2736997","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2736997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:08:08Z","timestamp":1790410088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2736997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2736997"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2736997","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}